• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    6/3/24 1:56:53 PM ET
    $ADRT
    $ADSK
    $AFMD
    $AMC
    Blank Checks
    Finance
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADRT alert in real time by email

    Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.

    SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate, according to data from Benzinga Pro.

    SAIC shares dipped 11% to $119.91 on Monday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Microbot Medical Inc. (NASDAQ:MBOT) jumped 92.5% to $1.9301 after the company received FDA approval to proceed with its pivotal human clinical trial.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares jumped 75% to $3.62. Bio-Path presented interim results from Phase 2 study of Prexigebersen (BP1001) in combination with decitabine and venetoclax for acute myeloid leukemia at the American Society Of Clinical Oncology Annual Meeting.
    • GameStop Corp. (NYSE:GME) shares climbed 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.
    • Professional Diversity Network, Inc. (NASDAQ:IPDN) gained 28.5% to $0.65. Professional Diversity Network recently named Megan Bozzuto as interim CFO.
    • MarineMax, Inc. (NYSE:HZO) gained 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 27% to $0.1271 after dipping 12% on Friday.
    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) climbed 26.5% to $0.4425 after the company reported an agreement to acquire Oxylus Global.
    • Dogness (International) Corporation (NASDAQ:DOGZ) gained 23.5% to $13.65
    • Affimed N.V. (NASDAQ:AFMD) gained 22.2% to $5.25 as the company issued follow-up data of AFM24 plus atezolizumab showing durable responses in heavily pretreated NSCLC EGFR wild-type patients and positive initial data from the NSCLC EGFR mutant cohort.
    • Concord Medical Services Holdings Limited (NYSE:CCM) rose 17.6% to $0.5883.
    • MacroGenics, Inc. (NASDAQ:MGNX) rose 17.5% to $4.8001.
    • Personalis, Inc. (NASDAQ:PSNL) gained 17.5% to $1.5282.
    • Liquidia Corporation (NASDAQ:LQDA) gained 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics’ request to block YUTREPIA™ launch.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) rose 15.5% to $11.18.
    • Stericycle, Inc. (NASDAQ:SRCL) gained 15% to $59.28 after the company announced that it entered into a definitive agreement to be acquired by Waste Management.
    • Precigen, Inc. (NASDAQ:PGEN) rose 15% to $1.61 after reporting study data for PRGN-2012 for recurrent respiratory papillomatosis patients.
    • Coherent Corp. (NASDAQ:COHR) gained 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.
    • CG Oncology, Inc. (NASDAQ:CGON) rose 11.8% to $36.34
    • Structure Therapeutics Inc. (NASDAQ:GPCR) rose 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) gained 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.
    • Novavax, Inc. (NASDAQ:NVAX) gained 10.7% to $16.65.
    • Telephone and Data Systems, Inc. (NYSE:TDS) rose 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares gained 8.8% to $0.6348 after gaining over 3% on Friday. 
    • Autodesk, Inc. (NASDAQ:ADSK) gained 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.
    • Molecular Partners AG (NASDAQ:MOLN) shares climbed 8.2% to $4.0699. Molecular Partners presented data from completed Phase 1 trial of MP0317 monotherapy in advanced solid tumors at ASCO 2024.

    Losers

    • CalAmp Corp. (NASDAQ:CAMP) shares fell 61.4% to $1.03 after the company said it has entered into a Restructuring Support Agreement with its principal secured lender, Lynrock Lake Master Fund LP, who will become the principal equity owner of CalAmp and take the Company private.
    • Ault Disruptive Technologies Corporation (NASDAQ:ADRT) fell 52.2% to $21.50.
    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) fell 32.3% to $0.1463. CNS Pharmaceuticals announced a 1-for-50 reverse stock split.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) fell 30% to $0.1536. Galera Therapeutics will be delisted by Nasdaq.
    • Portage Biotech Inc (NASDAQ:PRTG) shares fell 29.7% to $0.3365 after gaining over 91% on Friday.
    • 1847 Holdings LLC (NYSE:EFSH) dipped 29.5% to $0.7895.
    • FOXO Technologies Inc. (NYSE:FOXO) fell 26.3% to $0.3501.
    • iSpecimen Inc. (NASDAQ:ISPC) shares declined 24.4% to $0.3251.
    • Webuy Global Ltd (NASDAQ:WBUY) fell 23.7% to $0.1870.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) fell 21.2% to $2.67.
    • Vintage Wine Estates, Inc. (NASDAQ:VWE) fell 19.2% to $0.2883.
    • Latam Logistic Properties, S.A. (NYSE:LPA) fell 19.2% to $105.00
    • Brand Engagement Network, Inc. (NASDAQ:BNAI) shares fell 16.4% to $4.55 after jumping over 110% on Friday.
    • Lattice Semiconductor Corporation (NASDAQ:LSCC) fell 15.1% to $63.00 after the company announced an interim CEO following Jim Anderson’s decision to step down as President, CEO and Board member to pursue an opportunity with another company.
    • Latam Logistic Properties, S.A. (NYSE:LPA) dipped 13.8% to $112.00.
    • Digital Health Acquisition Corp (NASDAQ:DHAC) shares fell 10.3% to $15.25 after gaining 13% on Friday.
    • Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:OMAB) declined 10.2% to $73.44.
    • Immunocore Holdings plc (NASDAQ:IMCR) fell 10.1% to $44.05.
    • Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:PAC) fell 10% to $169.23.
    • GSK plc (NYSE:GSK) fell 8.7% to $40.87 after the company said it will appeal a ruling made by the Delaware State Court regarding its ongoing ranitidine litigation.
    • The Scotts Miracle-Gro Company (NYSE:SMG) declined 7.7% to $64.33.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) fell 7.7% to $20.81.
    • Dell Technologies Inc. (NYSE:DELL) fell 7.1% to $129.63. On May 30, Dell reported upbeat earnings and sales results for the first quarter.
    • Vistra Corp. (NYSE:VST) dipped 6.5% to $92.61.

    The Boston Beer Company, Inc. (NYSE:SAM) shares fell 4.7% to $299.07. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.

    Now Read This: This MongoDB Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

    Get the next $ADRT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADRT
    $ADSK
    $AFMD
    $AMC

    CompanyDatePrice TargetRatingAnalyst
    Autodesk Inc.
    $ADSK
    3/2/2026$343.00 → $279.00Market Perform
    BMO Capital Markets
    Olema Pharmaceuticals Inc.
    $OLMA
    2/11/2026$48.00Buy
    Stifel
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    Vistra Corp.
    $VST
    2/10/2026$203.00Hold → Buy
    Jefferies
    Vistra Corp.
    $VST
    2/6/2026$205.00Neutral → Buy
    Goldman
    Autodesk Inc.
    $ADSK
    2/2/2026$319.00Neutral → Overweight
    Analyst
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    More analyst ratings

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & CAO Scheiwer Mark J bought $49,504 worth of shares (693 units at $71.44), increasing direct ownership by 5% to 15,370 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/25/26 11:29:13 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

    In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* GSK plc (LSE/NYSE:GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18 to 49 years at increased risk for lower respiratory tract disease (LRTD) caused by RSV. AREXVY was previously approved in the US for the prevention of RSV-related LRTD in adults aged 60 and older, and adults aged 50–59 at increased risk for LRTD caused by RSV. This vaccine is not for use in pregnant individuals. Sanjay Gurunathan, GSK Head of Vaccines and Infectious Diseases Re

    3/13/26 11:44:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SAIC Board of Directors Declares Cash Dividend

    RESTON, Va., March 13, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company's board of directors declared a cash dividend of $0.37 per share of the company's common stock payable on April 24, 2026 to stockholders of record on April 10, 2026. SAIC intends to continue paying dividends on a quarterly basis, although the declaration of any future dividends will be determined by the board of directors each quarter and will depend on earnings, financial condition, capital requirements and other factors. About SAICSAIC® is a premier Fortune 500 mission integrator focused on advancing the power of technology and innovation to serve and

    3/13/26 8:15:00 AM ET
    $SAIC
    EDP Services
    Technology

    Coherent Advances Scale-Across Networks with Significant Enhancements to Its Multi-Rail Transport Platform

    SAXONBURG, Pa., March 12, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR), a global leader in photonics, today announced advancements in its scale-across portfolio, including its multi-rail optical transport platform combined with its Datacenter Interconnect (DCI) transceivers. These innovations address the accelerating bandwidth and efficiency requirements demanded by artificial intelligence (AI) network expansion. Coherent has significantly enhanced its compact multi-rail platform for improved efficiency in transport equipment, enabling four C+L band transport rails within a single 1RU in-line amplifier (ILA) card. This resource pooling innovation results in unprecedented system pow

    3/12/26 4:05:00 PM ET
    $COHR
    Electronic Components
    Technology

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shiver John W. converted options into 7,947 shares (SEC Form 4)

    4 - NOVAVAX INC (0001000694) (Issuer)

    3/12/26 5:00:14 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Kirk Randal J was granted 28,490 shares (SEC Form 4)

    4 - PRECIGEN, INC. (0001356090) (Issuer)

    3/12/26 4:35:47 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Turley James S was granted 17,806 shares, increasing direct ownership by 3% to 613,578 units (SEC Form 4)

    4 - PRECIGEN, INC. (0001356090) (Issuer)

    3/12/26 4:29:13 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Autodesk with a new price target

    BMO Capital Markets reiterated coverage of Autodesk with a rating of Market Perform and set a new price target of $279.00 from $343.00 previously

    3/2/26 8:16:50 AM ET
    $ADSK
    Computer Software: Prepackaged Software
    Technology

    Stifel initiated coverage on Olema Pharmaceuticals with a new price target

    Stifel initiated coverage of Olema Pharmaceuticals with a rating of Buy and set a new price target of $48.00

    2/11/26 7:52:37 AM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    B. Riley Securities initiated coverage on Microbot Medical with a new price target

    B. Riley Securities initiated coverage of Microbot Medical with a rating of Buy and set a new price target of $5.00

    2/10/26 8:01:31 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADRT
    $ADSK
    $AFMD
    $AMC
    SEC Filings

    View All

    SEC Form 6-K filed by Molecular Partners AG

    6-K - MOLECULAR PARTNERS AG (0001745114) (Filer)

    3/13/26 1:29:31 PM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Telephone and Data Systems Inc. filed SEC Form 8-K: Leadership Update

    8-K - TELEPHONE & DATA SYSTEMS INC /DE/ (0001051512) (Filer)

    3/13/26 8:48:37 AM ET
    $TDS
    Telecommunications Equipment
    Telecommunications

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/13/26 8:13:23 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADRT
    $ADSK
    $AFMD
    $AMC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Leadership Updates

    Live Leadership Updates

    View All

    Grupo Aeroportuario del Pacifico Announces Annual Ordinary General Shareholder's Meeting

    GUADALAJARA, Mexico, March 09, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:PAC, BMV:GAP) ("the Company" or "GAP") announces the following: Pursuant to a resolution adopted by the Board of Directors at its meeting held on February 23, 2026, and in accordance with Articles 180, 181 and other applicable articles of the Mexican General Corporations Law, as well as Article Thirty-Fifth of the Company's bylaws, GAP invite its shareholders to the Annual Ordinary General Shareholders' Meeting, to be held at 12:00 p.m. on April 22, 2026, at Midtown Ballroom 3, 3rd floor of the Hilton Midtown Hotel, located at Av. López Mateos 2405-300, Col. Italia Providencia, C

    3/9/26 6:10:17 PM ET
    $PAC
    Aerospace
    Transportation

    Coherent to Join the S&P 500

    SAXONBURG, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, today announced it will join the S&P 500 index, effective Monday, March 23. Jim Anderson, CEO, said, "Joining the S&P 500 is a testament to the strength of our team, the power of our technology portfolio, and the trust our customers have placed in us. As optical interconnects and photonic solutions become foundational to scaling next-generation AI data center infrastructure, Coherent is uniquely positioned to drive innovation and deliver enhanced value to our shareholders." Regarded as the leading benchmark for U.S. large-cap equities, the S&P

    3/9/26 9:06:18 AM ET
    $COHR
    Electronic Components
    Technology

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Financials

    Live finance-specific insights

    View All

    SAIC Board of Directors Declares Cash Dividend

    RESTON, Va., March 13, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company's board of directors declared a cash dividend of $0.37 per share of the company's common stock payable on April 24, 2026 to stockholders of record on April 10, 2026. SAIC intends to continue paying dividends on a quarterly basis, although the declaration of any future dividends will be determined by the board of directors each quarter and will depend on earnings, financial condition, capital requirements and other factors. About SAICSAIC® is a premier Fortune 500 mission integrator focused on advancing the power of technology and innovation to serve and

    3/13/26 8:15:00 AM ET
    $SAIC
    EDP Services
    Technology

    Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

    GERMANTOWN, Md., March 11, 2026 /PRNewswire/ -- Precigen, Inc. (NASDAQ:PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release full year 2025 financial results and provide business updates on Wednesday, March 25, 2026. The Company will host a conference call to discuss results that day at 4:30 PM ET. The conference call may be accessed by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (International). Participants are asked to dial in

    3/11/26 4:05:00 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZIM Reports Financial Results for the Fourth Quarter and the Full Year of 2025

    Reported Full Year Revenues of $6.90 Billion, Net Income of $481 Million1, Adjusted EBITDA2 of $2.17 Billion and Adjusted EBIT2 of $885 Million3Generated Full Year Adjusted EBITDA and Adjusted EBIT Margins2 of 31% and 13%, Respectively Declared Q4 2025 Dividend of Approximately $106 Million, or $0.88 per Share, Representing, Together with Previous Dividends Distributed on Account of 2025 Results, Approximately 50% of the Full Year 2025 Net Income Dividends to Total Approximately $5.8 Billion Over Last Five Years—More Than 25 Times the Amount Raised at IPO in January 2021HAIFA, Israel, March 9, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company"), a g

    3/9/26 7:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $ADRT
    $ADSK
    $AFMD
    $AMC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Olema Pharmaceuticals Inc.

    SC 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    12/11/24 4:30:15 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Olema Pharmaceuticals Inc.

    SC 13D/A - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    12/4/24 7:49:50 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Direct Digital Holdings Inc.

    SC 13D/A - Direct Digital Holdings, Inc. (0001880613) (Subject)

    11/22/24 4:11:23 PM ET
    $DRCT
    Advertising
    Consumer Discretionary